Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)

Press/Media

Period2 Jun 2024

Media coverage

158

Media coverage